ResMed (RMD) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $191.26 --0%
Revenue Growth %: +13.1%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: +13.1%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
